3

FORM 3 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: June 25, 2020
Period of Report: June 24, 2020
Accession Number: 0001209191-20-039032

View Document ↗ View on SEC.gov ↗